In a significant stride toward advancing reproductive health, ReproNovo has successfully raised $65 million through a Series A funding round. This substantial investment marks a pivotal moment in the landscape of biopharmaceutical development focused on addressing fertility and uterine health
In the fast-paced world of medical diagnosis and treatment, the speed at which accurate results are obtained can often be the deciding factor in outcomes. This is especially true in dealing with bacterial infections, where the timely and precise administration of antibiotics is crucial. One area of
In the rapidly evolving landscape of life sciences, the challenges plaguing drug development have become more pronounced, prompting an urgent need for transformation. The industry has long grappled with prolonged cycle times, substantial costs, and steep complexities in clinical trials that delay
In the rapidly evolving digital landscape, Britain's National Health Service (NHS) has become an attractive target for cybercriminals. Over recent years, incidents have highlighted vulnerabilities in the system, posing significant risks to patient safety and service delivery. Two major cyberattacks
Recent advancements in biotechnology have paved the way for innovative solutions in DNA research, with automation playing a pivotal role. Thermo Fisher's KingFisher PlasmidPro system emerges as a significant breakthrough, promising to streamline the traditionally tedious plasmid DNA maxi-prep
Biovica International, known for its innovations in blood-based cancer monitoring, recently unveiled a strategic collaboration with a prominent US-based Tier-1 pharmaceutical company. This partnership reflects a mutual commitment to pioneering advancements in cancer treatment. The alliance
